Obesity-related glomerulopathy: Insights from gene expression profiles of the glomeruli derived from renal biopsy samples

Endocrinology

Volumn 147, Issue 1, 2006, Pages 44-50

  Wu, Yichao ^a   Liu, Zhihong ^a   Xiang, Zhaoying ^b   Zeng, Caihong ^a   Chen, Zhaohong ^a   Ma, Xiaojing ^b   Li, Leishi ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; FATTY ACID BINDING PROTEIN; GAMMA INTERFERON; GLUCOSE TRANSPORTER 1; INTERLEUKIN 6; LEPTIN RECEPTOR; LOW DENSITY LIPOPROTEIN RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; VASCULOTROPIN;

ADULT; ARTICLE; BIOINFORMATICS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GLOMERULOPATHY; GLOMERULUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INSULIN RESISTANCE; KIDNEY BIOPSY; LIPID METABOLISM; MALE; MICROARRAY ANALYSIS; MICRODISSECTION; MICROSCOPE; NUCLEOTIDE SEQUENCE; OBESITY; OBESITY RELATED GLOMERULOPATHY; PRIORITY JOURNAL; PROTEINURIA; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; STAINING; STATISTICAL SIGNIFICANCE;

ADULT; ANIMALS; BASE SEQUENCE; DISEASE MODELS, ANIMAL; DNA PRIMERS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; KIDNEY DISEASES; KIDNEY GLOMERULUS; MALE; MIDDLE AGED; OBESITY; RATS; RECEPTORS, CELL SURFACE; RECEPTORS, LDL; REFERENCE VALUES; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 29344466239     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2005-0641     Document Type: Article

References (35)

1. Visscher TL, Seidell JC 2001 The public health impact of obesity. Annu Rev Public Health 22:355-375
2. Flegal KM, Carroll MD, Kuczmarski RJ, Johnson CL 1998 Overweight and obesity in the United States: prevalence and trends, 1960-1994. Int J Obes Relat Metab Disord 22:39-47
3. Herrara MF, Lozano-Salazar RR, Gonzalez-Barranco J, Rull JA 1999 Diseases and problems secondary to massive obesity. Eur J Gastroenterol Hepatol 11:63-67
4. Hall JE 1994 Renal and cardiovascular mechanisms of hypertension in obesity. Hypertension 23:381-394
5. Rosenbaum M, Leibel RL, Hirsch J 1997 Obesity. N Engl J Med 337:396-407
6. Weisinger JR, Kempson RL, Eldridge L, Swenson RS 1974 The nephrotic syndrome: a complication of massive obesity. Ann Intern Med 81:440-447
7. Warnke RA, Kempson R 1978 The nephrotic syndrome in massive obesity. A study by light, immunofluorescence and electron microscopy. Arch Pathol Lab Med 102:431-438
8. Verani RR 1992 Obesity associated focal segmental glomerulosclerosis: pathological features of the lesion and relationship with cardiomegaly and hyperlipidemia. Am J Kidney Dis 20:629-634
9. Kambham N, Markowitz GS, Valeri AM, Lin J, D'Agati VD 2001 Obesity-related glomerulopathy: an emerging epidemic. Kidney Int 59:1498-1509
10. Chagnac A, Weinstein T, Korzets A, Ramadan E, Hirsch J, Gafter U 2000 Glomerular hemodynamics in severe obesity. Am J Physiol Renal Physiol 278:F817-F822
11. Kasiske BL, Napier J 1985 Glomerular sclerosis in patients with massive obesity. Am J Nephrol 5:45-50
12. Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW, Allen K, Lopes M, Savoye M, Morrison J, Sherwin RS, Caprio S 2004 Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 350:2362-2374
13. Gershon D 2002 Microarray technology: an array of opportunities. Nature 416:885-889
14. Liu ZH, Striker LJ, Hattori M, Yang CW, Striker GE 1996 Localization of glutamic acid decarboxylase in the kidneys of nonobese diabetic mice. Nephron 72:662-666
15. Esposito C, Liu ZH, Striker GE, Phillips C, Chen NY, Chen WY, Kopchick JJ, Striker LJ 1996 Inhibition of diabetic nephropathy by a GH antagonist: a molecular analysis. Kidney Int 560:506-514
16. 1997 Preventing and managing the global epidemic of obesity: report of the World Health Organization consultation of obesity. Geneva, Switzerland: World Health Organization
17. Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, Speed TP 2003 Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res 31:e15
18. Dadi HK, Simon AJ, Roifman CM 2003 Effect of CD3δ deficiency on maturation of α/β and γ/δ T-cell lineages in severe combined immunodeficiency. N Engl J Med 349:1821-1828
19. Cousins RJ, Blanchard RK, Popp MP, Liu L, Cao J, Moore JB, Green CL 2003 A global view of the selectivity of zinc deprivation and excess on genes expressed in human THP-1 mononuclear cells. Proc Natl Acad Sci USA 100:6952-6957
20. Xiang Z, Yang Y, Ma X, Ding W 2003 Microarray expression profiling: analysis and applications. Curr Opin Drug Discov Dev 6:384-395
21. Liu G, Loraine AE, Shigeta R, Cline M, Cheng J, Valmeekam V, Sun S, Kulp D, Siani-Rose MA 2003 NetAffx: Affymetrix probesets and annotations. Nucleic Acids Res 31:82-86
22. Eikmans M, Sijpkens YW, Baelde HJ, de Heer E, Paul LC, Bruijn JA 2002 High transforming growth factor-β and extracellular matrix mRNA response in renal allografts during early acute rejection is associated with absence of chronic rejection. Transplantation 73:573-579
23. Borst SE 2004 The Role of TNF-α in insulin resistance. Endocrine 23:177-182
24. Waite KJ, Floyd ZE, Arbour-Reily P, Stephens JM 2001 Interferon-γ- induced regulation of peroxisome proliferator-activated receptor γ and STATs in adipocytes. J Biol Chem 276:7062-7068
25. Wellen KE, Hotamisligil GS 2003 Obesity-induced inflammatory changes in adipose tissue. J Clin Invest 112:1785-1788
26. Brix-Christensen V, Gjedsted J, Andersen SK, Vestergaard C, Nielsen J, Rix T, Nyboe R, Andersen NT, Larsson A, Schmitz O, Tonnesen E 2005 Inflammatory response during hyperglycemia and hyperinsulinemia in a porcine endotoxemic model: the contribution of essential organs. Acta Anaesthesiol Scand 49:991-998
27. Hu KB, Liu ZH, Zhou H, Li LS 2000 Up-regulation of VEGF and VEGF receptor in glomeruli associated with marked proteinuria and endothelial damage in patients with type 2 diabetic nephropathy. J Am Soc Nephrol 11:116A
28. Joles JA, Kunter U, Janssen U, Kriz W, Rabelink TJ, Koomans HA, Floege J 2000 Early mechanisms of renal injury in hypercholesterolemic or hypertriglyceridemic rats. J Am Soc Nephrol 11:669-683
29. Streicher R, Kotzka J, Muller-Wieland D, Siemeister G, Munck M, Avci H, Krone W 1996 SREBP-1 mediates activation of the low density lipoprotein receptor promoter by insulin and insulin-like growth factor-I. J Biol Chem 271:7128-7133
30. Liu ZH, Li YJ, Chen ZH, Liu D, Li LS 2001 Glucose transporter in human glomerular mesangial cells modulated by transforming growth factor-β and rhein. Acta Pharmacol Sin 22:169-175
31. Liu ZH, Guan TJ, Chen ZH, Li LS 1999 Glucose transporter (GLUT1) allele (XbaI-) associated with nephropathy in non-insulin-dependent diabetes mellitus. Kidney Int 55:1843-1848
32. Wolf G, Hamann A, Han DC, Helmchen U, Thaiss F, Ziyadeh FN, Stahl RAK 1999 Leptin stimulates proliferation and TGF-β expression in renal glomerular endothelial cells: potential role in glomerulosclerosis. Kidney Int 56:860-872
33. Wilson KH, Eckenrode SE, Li QZ, Ruan QG, Yang P, Shi JD, Davoodi-Semiromi A, McIndoe RA, Croker BP, She JX 2003 Microarray analysis of gene expression in the kidneys of new- and post-onset diabetic NOD mice. Diabetes 52:2151-2159
34. Sreekumar R, Halvatsiotis P, Schimke JC, Nair KS 2002 Gene expression profile in skeletal muscle of type 2 diabetes and the effect of insulin treatment. Diabetes 51:1913-1920
35. Liang K, Vaziri ND 1999 Down-regulation of hepatic high-density lipoprotein receptor, SR-B1, in nephrotic syndrome. Kidney Int 56:621-626